| Adjuvant chemotherapy in osteogenic sarcoma: the triumph that isn't? |
| SK Carter |
|
JCO Mar 1 1984: 147–148.
[PDF]
|
 |
| The treatment of locally advanced breast cancer |
| GP Canellos |
|
JCO Mar 1 1984: 149–151.
[PDF]
|
|
|
A controlled pilot study of high-dose methotrexate as postsurgical adjuvant treatment for primary osteosarcoma |
| |
JH Edmonson, SJ Green, JC Ivins, GS Gilchrist, ET Creagan, DJ Pritchard, WA Smithson, DC Dahlin, and WF Taylor |
| |
JCO Mar 1 1984: 152–156.
[Abstract]
[PDF]
|
|
|
Aggressive combined modality therapy for advanced local-regional breast carcinoma |
| |
CL Loprinzi, PP Carbone, DC Tormey, PR Rosenbaum, W Caldwell, JC Kline, RA Steeves, and G Ramirez |
| |
JCO Mar 1 1984: 157–163.
[Abstract]
[PDF]
|
|
|
Randomized phase III trial of vinblastine, bleomycin, and cis- dichlorodiammine-platinum versus dacarbazine in malignant melanoma |
| |
SD Luikart, GT Kennealey, and JM Kirkwood |
| |
JCO Mar 1 1984: 164–168.
[Abstract]
[PDF]
|
|
|
Brain metastases in patients with renal cell carcinoma: prognosis and treatment |
| |
DA Decker, VL Decker, A Herskovic, and GD Cummings |
| |
JCO Mar 1 1984: 169–173.
[Abstract]
[PDF]
|
|
|
Prognostic factors influencing survival of patients with advanced colorectal cancer: hepatic-artery infusion versus systemic intravenous chemotherapy for liver metastases |
| |
AY Bedikian, TT Chen, MA Malahy, YZ Patt, and GP Bodey |
| |
JCO Mar 1 1984: 174–180.
[Abstract]
[PDF]
|
|
|
Criteria for monitoring carcinoembryonic antigen: variability of sequential assays at elevated levels |
| |
JJ Lokich, S Ellenberg, and B Gerson |
| |
JCO Mar 1 1984: 181–186.
[Abstract]
[PDF]
|
|
|
Karnofsky performance status revisited: reliability, validity, and guidelines |
| |
CC Schag, RL Heinrich, and PA Ganz |
| |
JCO Mar 1 1984: 187–193.
[Abstract]
[PDF]
|
|
|
Prognostic significance of erythrocyte sedimentation rate in clinical stages I-II of Hodgkin's disease |
| |
M Tubiana, M Henry-Amar, MV Burgers, B van der Werf-Messing, and M Hayat |
| |
JCO Mar 1 1984: 194–200.
[Abstract]
[PDF]
|
|
|
Small cell bronchogenic carcinoma: factors associated with pneumonia during chemotherapy |
| |
CL Dixon, M Valdivieso, T Umsawasdi, G Dubois, D Patton, T Chen, MK Ali, and GP Bodey |
| |
JCO Mar 1 1984: 201–206.
[Abstract]
[PDF]
|
|
|
Increased therapeutic index of weekly doxorubicin in the therapy of non- small cell lung cancer: a prospective, randomized study |
| |
M Valdivieso, MA Burgess, MS Ewer, B Mackay, S Wallace, RS Benjamin, MK Ali, GP Bodey, and EJ Freireich |
| |
JCO Mar 1 1984: 207–214.
[Abstract]
[PDF]
|
|
|
Penetration of VP 16-213 into cerebrospinal fluid after high-dose intravenous administration |
| |
PE Postmus, JJ Holthuis, H Haaxma-Reiche, NH Mulder, LM Vencken, WJ van Oort, DT Sleijfer, and HJ Sluiter |
| |
JCO Mar 1 1984: 215–220.
[Abstract]
[PDF]
|
|
|
Comparison of the biologic effects of two recombinant human interferons alpha (rA and rD) in humans |
| |
MJ Hawkins, EC Borden, JA Merritt, BS Edwards, LA Ball, E Grossbard, and KJ Simon |
| |
JCO Mar 1 1984: 221–226.
[Abstract]
[PDF]
|
|
|
Polar solvents: a novel class of antineoplastic agents |
| |
EN Spremulli and DL Dexter |
| |
JCO Mar 1 1984: 227–241.
[Abstract]
[PDF]
|
|
| Is T3NOMO breast cancer with pathologically negative nodes truly stage III? |
|
|
JCO Mar 1 1984: 242–243.
[PDF]
|
|
| Alternating combination chemotherapy improves survival in multiple myeloma: a Southwest Oncology Group study |
|
|
JCO Mar 1 1984: 243–248.
[PDF]
|
|
